Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure

NCT06621576 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06621576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06621576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure
Lead sponsor
Ruijin Hospital
Phase
Phase 1
Overall status
Completed
Start date
September 18, 2024
Completion date
May 26, 2025
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, ischaemic heart disease